Advertisement
Screener

OMEROS CORP (OMER) Debt / Equity

OMEROS CORP (OMER) Debt / Equity

  • 2018-09-30: Debt/Equity Ratio -1.49.
  • 2018-06-30: Debt/Equity Ratio -2.32.
  • 2018-03-31: Debt/Equity Ratio -2.93.
  • 2017-12-31: Debt/Equity Ratio -30.07.

Complete source-backed debt/equity ratio history.

Available history
2011-12-31 to 2018-09-30
Data captured

Historical Debt/Equity Ratio

DateDebt/Equity Ratio
2018-09-30-1.49
2018-06-30-2.32
2018-03-31-2.93
2017-12-31-30.07
2017-09-309.03
2017-06-30-1.49
2017-03-31-1.68
2016-12-31-2.13
2016-09-30-3.09
2016-06-30-1.43
2016-03-31-1.23
2015-12-31-1.9
2015-09-30-3.17
2015-06-303.88
2015-03-311.51
2014-12-31-0.76
2014-09-30-1.22
2014-06-30-3.05
2014-03-316.18
2013-12-31-1.11
2013-09-30-0.85
2013-06-30-1.66
2013-03-31-1.27
2012-12-31-3.08
2011-12-31-3.5

Annual Debt/Equity Ratio

DateDebt/Equity Ratio
2017-12-31-30.07
2016-12-31-2.13
2015-12-31-1.9
2014-12-31-0.76
2013-12-31-1.11
2012-12-31-3.08
2011-12-31-3.5

Similar stocks

Stock NameCountryMarket CapPE Ratio
Ultragenyx Pharmaceutical Inc. (RARE)United States$1.456B-5.62
ArriVent BioPharma, Inc. (AVBP)United States$1.485B-10.25
Innoviva, Inc. (INVA)United States$1.493B4.62
Oric Pharmaceuticals, Inc. (ORIC)United States$1.367B-8.00
ANAPTYSBIO, INC (ANAB)United States$1.546B-60.20
Kailera Therapeutics, Inc. (KLRA)United States$1.552B
Kardigan, Inc. (KARD)United States$1.346B
Tyra Biosciences, Inc. (TYRA)United States$1.337B-12.83
Bicara Therapeutics Inc. (BCAX)United States$1.309B-10.55
Syndax Pharmaceuticals Inc (SNDX)United States$1.606B-8.82